Khoshakhlagh Amir Hossein, Yazdanirad Saeid, Laal Fereydoon, Sarsangi Vali
Department of Occupational Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, Iran; Department of Occupational Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Chin J Traumatol. 2019 Jun;22(3):142-147. doi: 10.1016/j.cjtee.2019.01.009. Epub 2019 Mar 22.
To determine the relationship of illnesses and medical drug consumption with the occurrence of traffic accidents among truck and bus drivers.
This is a cross-sectional study on truck and bus drivers in Tehran, Iran. The criteria for participating in this study were: married males over 30 years old, driving license in grade one, five years of job experience, mental health and non-addiction license. The criterion for not participating in this study was the lack of cooperation in responding to the questions. Six months was spent to collect the latest five years data of driving accidents from 2011 to 2016. A total of 323 truck and bus drivers in Tehran city and the suburbs, Iran were chosen. Among them, 112 were responsible for accidents (accident group) while 211 were not responsible for any accidents or involved in an accident in the last five years (non-accident group). A specially designed questionnaire was used to investigate the demographic information, medical drug consumption, medical backgrounds and history of accidents.
The results revealed that compared with healthy subjects, the occurrence of accidents among people with diabetes (OR = 2.3, p = 0.001) and vision weakness (OR = 1.7, p = 0.020) was significantly higher, while that among people with cardiac (OR = 0.5, p = 0.002) and hypertension (OR = 0.9, p = 0.048) problems was remarkably lower. Moreover, consumption of Gemfibrozil (OR = 1.8, p = 0.010) and Glibenclamide (OR = 2.2, p = 0.002) drugs resulted in significantly higher incidence of accidents than those without.
Frequencies of illnesses like cardiovascular and hypertension were not higher in accident drivers than in non-accident drivers; but diabetes, vision weakness and consumption of Gemfibrozil and Glibenclamide lead to more traffic accidents.
确定卡车和公交车司机的疾病及药物使用情况与交通事故发生之间的关系。
这是一项针对伊朗德黑兰卡车和公交车司机的横断面研究。参与本研究的标准为:30岁以上已婚男性、一级驾驶执照、五年工作经验、心理健康且无成瘾问题。不参与本研究的标准为不配合回答问题。花费六个月时间收集了2011年至2016年最近五年的驾驶事故数据。共选取了伊朗德黑兰市及郊区的323名卡车和公交车司机。其中,112人曾发生事故(事故组),211人在过去五年中未发生任何事故或未卷入事故(非事故组)。使用专门设计的问卷调查人口统计学信息、药物使用情况、病史及事故史。
结果显示,与健康受试者相比,糖尿病患者(OR = 2.3,p = 0.001)和视力不佳者(OR = 1.7,p = 0.020)发生事故的几率显著更高,而患有心脏问题(OR = 0.5,p = 0.002)和高血压(OR = 0.9,p = 0.048)的人发生事故的几率则显著更低。此外,服用吉非罗齐(OR = 1.8,p = 0.010)和格列本脲(OR = 2.2,p = 0.002)药物导致事故发生率显著高于未服用者。
事故司机中心血管疾病和高血压等疾病的发生率并不高于非事故司机;但糖尿病、视力不佳以及服用吉非罗齐和格列本脲会导致更多交通事故。